Shilpa Medicare Ltd
Ticker: SHILPAMED
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
356.65
Market Cap
6975.43
Debt/Equity
0.2487
ROE %
3.761
PB
2.9511
Promoter %
44.227
Pledge %
3.502
1Y Rev Growth %
12.409
5Y Rev Growth %
7.221
NP Margin %
5.974
NP Margin 5Y Avg %
5.149
Trading Reference
1M Return %
-15.042
6M Return %
8.793
1Y Return %
-19.474
% Away 52W High
40.193
% Away 52W Low
88.679
Daily Volume
396261
Investment Verdict
Risky
Score 52/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 15/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Shilpa Medicare Ltd is currently trading near a key support level, with recent volume indicating accumulation. If it breaks above the resistance at ₹500, there is potential for a bullish trend, targeting ₹550. Conversely, a drop below ₹450 could signal a bearish trend, with a target of ₹400.
Upside Probability: 10% | Downside Probability: 11%
Probability estimates are technical-context statements, not investment advice.
More Options
M
Manorama Industries Ltd
Manorama Industries Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
T
Thomas Cook (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Raymond Lifestyle Ltd
Raymond Lifestyle Ltd is facing several challenges that may hinder its growth potential, making it a risky investment at this time.
View details
P
P N Gadgil Jewellers Ltd
P N Gadgil Jewellers Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kirloskar Pneumatic Company Ltd
The company shows potential for growth but faces challenges in profitability and market competition.
View details
S
Sheela Foam Ltd
Sheela Foam Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
S
Sharda Cropchem Ltd
Sharda Cropchem Ltd shows decent potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
D
Diamond Power Infrastructure Ltd
Diamond Power Infrastructure Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
ESAB India Ltd
ESAB India Ltd shows decent potential with consistent growth and profitability metrics, but some risks in execution and governance need to be monitored.
View details
M
Marksans Pharma Ltd
Marksans Pharma Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
B
Balu Forge Industries Ltd
Balu Forge Industries Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Investors should proceed with caution.
View details
R
Rattanindia Enterprises Ltd
Rattanindia Enterprises Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
View details
G
Gujarat Pipavav Port Ltd
Gujarat Pipavav Port Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
M
Mahindra Lifespace Developers Ltd
Mahindra Lifespace Developers Ltd shows potential for growth but faces challenges in profitability and valuation compared to peers.
View details
T
Triveni Engineering and Industries Ltd
Triveni Engineering shows potential for growth but faces several risks that could impact its performance. Investors should proceed with caution.
View details
R
RRP Semiconductor Ltd
RRP Semiconductor Ltd shows potential for growth in a promising sector, but faces challenges in valuation and execution risks.
View details
Business Overview
Shilpa Medicare Ltd is a prominent Indian pharmaceutical company specializing in the development and manufacturing of generic and specialty medicines. Catering to both domestic and international markets, it plays a crucial role in enhancing healthcare accessibility. The company is committed to innovation and quality, ensuring that its products meet global standards. With a strong focus on research and development, Shilpa Medicare is positioned to address critical health challenges, making it a valuable player in the pharmaceutical landscape.
- Established leader in generic pharmaceuticals
- Strong focus on research and development
- Commitment to quality and compliance
- Expanding international presence
- Contributes to affordable healthcare solutions
Investment Thesis
Shilpa Medicare Ltd stands out due to its strong promoter credibility, which instills investor confidence. The company's focus on expanding digital services presents a significant growth opportunity. Additionally, its attractive valuation compared to peers makes it a compelling investment choice for retail investors seeking long-term gains.
- Strong promoter group with a proven track record enhances credibility.
- Expanding digital services sector offers substantial growth potential.
- Attractive valuation compared to industry peers provides a buying opportunity.
- Diversified product portfolio mitigates risks and supports revenue stability.
- Strategic partnerships and collaborations bolster market position.
Opportunity vs Risk
Opportunities
- Growing demand for generic drugs
- Expansion into international markets
- Strong pipeline of new products
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory changes affecting pricing
- Intense competition in pharmaceuticals
- Dependence on key patents
- Currency fluctuations impacting profits
Peer Perspective
Shilpa Medicare Ltd trades at a discount to peers like Sun Pharmaceutical and Dr. Reddy's, primarily due to margin pressures. A sustained improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Shilpa Medicare Ltd shows promise for growth in the pharmaceutical sector, contingent on effective execution of its expansion plans and stringent cost control measures to enhance profitability.
AI FAQs for Retail Users
- Q: What does Shilpa Medicare Ltd do?A: Shilpa Medicare Ltd is a pharmaceutical company focused on manufacturing and marketing generic medicines.
- Q: Is Shilpa Medicare Ltd a profitable company?A: The company has reported profits in recent years, but profitability can vary.
- Q: What are the main products of Shilpa Medicare Ltd?A: They primarily produce oncology and other specialty pharmaceuticals, including active pharmaceutical ingredients.
- Q: How can I invest in Shilpa Medicare Ltd?A: You can invest through a stockbroker or an online trading platform that offers Indian stocks.
- Q: What are the risks of investing in Shilpa Medicare Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical industry.
📊 Stock Investment Checklist (100 Points)
Shilpa Medicare Ltd • Updated: 2025-09-18 00:58:14
-
10BusinessHighPharmaceutical sector shows growth potential, but competition is high.
-
10GrowthHighConsistent revenue growth observed, but profit margins are fluctuating.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is not consistently strong.
-
8ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is strong, but some concerns over pledging.
-
5DriversGoodGrowth drivers exist, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Shilpa Medicare Ltd shows potential for growth, but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100